Accordingly, treatment of NOMO-1 with STAT3-inhibitor AG490 resulted in reduced STAT3-phosphorylation and concomitant downregulation of NANOG (Fig 7B), indicating that STAT3 activated NANOG in this AML cell line as well. The gene discussed is NANOG; the disease is acute myeloid leukemia.